Rating History for BioXcel Therapeutics (BTAI) by Lucid Capital Markets

More Stocks Rated by Lucid Capital Markets | Latest Ratings for BTAI
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/25/2025 N/A New Coverage Buy
(N/A)		 66.00
(N/A)		 1.73
(1.26)		 -27.17% Details